-
Novo Nordisk Smegglutide Approved for Cardiovascular Indications for the First Time
Recently, a new indication for the Novo Nordisk weight loss therapy Wegovy (Smegglutide) injection has been approved by the US FDA to reduce the risk of cardiovascular death, heart attack, and stroke ... -
Johnson&Johnson acquires shock wave equipment giant for $12.5 billion and increases its layout of cardiovascular medical devices
On April 5th, Johnson&Johnson announced the acquisition of medical device company Shockwave for $12.5 billion. The company's shockwave balloon device is used for intravascular lithotripsy (IVL), a tr ...